Enavate Sciences GP, LLC → Camp4 Therapeutics Corp CAMP

Stake: 8.10% Shares: 3,785,802 CUSIP: 13463J101 Class: Common Stock, $0.0001 par value per share

Item 4 — Purpose of Transaction

Item 4 of the Statement is amended and supplemented as follows: Effective September 9, 2025, James P. Boylan resigned from the Board of Directors of the Issuer.

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest · settle 2026-03-31

DTC 3.23

414,235 shares short · -14.3% vs prior

Other Filings by Enavate Sciences GP, LLC

Filed	Form	Issuer	Stake	Shares
2025-10-14	SCHEDULE	Zenas BioPharma, Inc. ZBIO	7.30%	3,919,159	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →